Paladin Labs logo — company profile

Paladin Labs

Founded 1983 Canada Montreal, Canada 132 employees Post-IPO Equity Total: $98.95M Biotechnology, Health Care +1

General Information

Company Name Paladin Labs
Founded Year 1983
Location Canada Montreal, Canada
Employees 132
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Paladin Labs. To contact Paladin Labs, visit paladin-labs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Paladin Labs compare?

A PDF of Paladin Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Paladin Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Paladin Labs

Paladin Labs is a specialty pharmaceutical company based in Montreal, Canada, and has been operating since 1983. The company is known for acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With a strong focus on Biotechnology, Health Care, and Pharmaceutical industries, Paladin has established itself as a prominent player in the Canadian pharmaceutical landscape. As of 01 February 2011, Paladin Labs received a significant $40.25M post-IPO equity investment, demonstrating confidence and support from investors. Although the specific investors are not mentioned, this substantial investment indicates a recognition of the company's potential within the pharmaceutical sector. Being an operating company of Endo International plc (NASDAQ: ENDP), Paladin Labs benefits from its association with a highly focused generics and specialty branded pharmaceutical company. This partnership reflects Paladin's commitment to delivering quality medicines to patients through excellence in development, manufacturing, and commercialization. In summary, Paladin Labs' strategic focus on the Canadian market, coupled with its diversified portfolio of pharmaceutical products, positions it as a key player in the industry. The recent substantial investment further underlines its potential for growth and innovation within the pharmaceutical sector.

Business keywords: pharmaceutical company, specialty pharmaceuticals, Canadian market, marketing and sales, product acquisition, licensing, innovative pharmaceuticals, Endo International, NASDAQ: ENDP, specialty branded pharmaceuticals, quality medicines, development, commercialization, Montreal

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $40.25M -
01 Feb 2011
Post IPO Equity $58.70M -
11 Jun 2009

Paladin Labs Alternatives & Competitors

View All Alternatives
Paladin Labs vs

Searchlight Pharma is a Montreal-based company with global reach that executes best-in-class search,...

Private Equity
57 employees
Health Care, Pharmaceutical
Paladin Labs vs

Providing healthcare professionals and patients with innovative therapeutic solutions to improve qua...

Post-IPO Debt
88 employees
Biotechnology, Health Care
Paladin Labs vs

Pioneering pain management with innovative products and advanced abuse prevention technologies

Post-IPO Equity
Biopharma, Biotechnology

FAQ About Paladin Labs

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. Paladin has a focused marketing and sales organization that has helped it evolve into a well-known Canadian spe...
Paladin Labs was founded in 1983.
Paladin Labs is headquartered in Montreal, Canada.
Paladin Labs operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharmaceutical company, specialty pharmaceuticals, Canadian market and marketing and sales.
Paladin Labs has approximately 132 employees.
Paladin Labs has completed 2 funding rounds, raising a total of $98.95M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Paladin Labs include Searchlight Pharma Inc., Valeo Pharma, QRxPharma, AMW GmbH, Orbicular Pharmaceutical Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Paladin Labs and Searchlight Pharma Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Paladin Labs, https://bouncewatch.com/company/paladin-labs, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes